United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. (2001). Better pharmaceuticals for children: Assessment and opportunities : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Seventh Congress, first session on examining the impact of the pediatric exclusivity provision of the better pharmaceuticals for children act, which grants a pharmaceutical company an additional 6 months of market exclusivity for new or marketed drugs in exchange for conducting pediatric studies requested by the Food and Drug Administration, May 8, 2001. U.S. Government Printing Office.
Chicago Style (17th ed.) CitationUnited States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Better Pharmaceuticals for Children: Assessment and Opportunities : Hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Seventh Congress, First Session on Examining the Impact of the Pediatric Exclusivity Provision of the Better Pharmaceuticals for Children Act, Which Grants a Pharmaceutical Company an Additional 6 Months of Market Exclusivity for New or Marketed Drugs in Exchange for Conducting Pediatric Studies Requested by the Food and Drug Administration, May 8, 2001. Washington: U.S. Government Printing Office, 2001.
MLA (9th ed.) CitationUnited States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Better Pharmaceuticals for Children: Assessment and Opportunities : Hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Seventh Congress, First Session on Examining the Impact of the Pediatric Exclusivity Provision of the Better Pharmaceuticals for Children Act, Which Grants a Pharmaceutical Company an Additional 6 Months of Market Exclusivity for New or Marketed Drugs in Exchange for Conducting Pediatric Studies Requested by the Food and Drug Administration, May 8, 2001. U.S. Government Printing Office, 2001.